Get started
ISHARES IV PLC NASDAQ US BIOTECH UCITS USD ACCISHARES IV PLC NASDAQ US BIOTECH UCITS USD ACCISHARES IV PLC NASDAQ US BIOTECH UCITS USD ACC

ISHARES IV PLC NASDAQ US BIOTECH UCITS USD ACC

No trades
See on Supercharts
Overview
Analysis
Holdings News Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪9.07 B‬ MXN
Fund flows (1Y)
‪−587.42 M‬ MXN
Dividend yield (indicated)
—
Discount/Premium to NAV
7.10%
Shares outstanding
‪1.44 B‬
Expense ratio
0.35%

About ISHARES IV PLC NASDAQ US BIOTECH UCITS USD ACC


Issuer
BlackRock, Inc.
Brand
iShares
Home page
ishares.com
Inception date
Oct 19, 2017
Structure
Irish VCIC
Index tracked
NASDAQ Biotechnology Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
BlackRock Asset Management Ireland Ltd.
ISIN
IE00BYXG2H39
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of March 28, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.78%
Health Technology95.74%
Finance1.41%
Commercial Services1.19%
Technology Services0.83%
Health Services0.59%
Process Industries0.02%
Bonds, Cash & Other0.22%
Cash0.22%
Stock breakdown by region
0%84%15%0.4%
North America84.39%
Europe15.14%
Asia0.43%
Oceania0.04%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows